Showing results (651-660 of 764) with videos related to

Sort By:
Pageof 77
Journal of Medicinal Chemistry|March 6, 2020
Discovery and Optimization of a Compound Series Active against Trypanosoma cruzi, the Causative Agent of Chagas DiseaseJustin R Harrison, Sandipan Sarkar, Shahienaz Hampton, et al.
Blood|September 26, 2012
Human red blood cells at work: identification and visualization of erythrocytic eNOS activity in health and diseaseMiriam M Cortese-Krott, Ana Rodriguez-Mateos, Roberto Sansone, et al.
Antioxidants & Redox Signaling|June 29, 2023
A Systematic Review and Comprehensive Evaluation of Human Intervention Studies to Unravel the Bioavailability of Hydroxycinnamic AcidsGiuseppe Di Pede, Pedro Mena, Letizia Bresciani, et al.
American Journal of Human Genetics|August 3, 2026
Cell villages and Dirichlet modeling map human cell fitness geneticsChloe Hanson, Timothy Derebenskiy, Ana Rodriguez Vega, et al.
Medicine|November 25, 2020
Cross-sectional evaluation of the interaction between activity relative-time expenditure and comorbidity concerning physical quality of lifeRafael Suarez-Villar, Diego Martinez-Urbistondo, Maria Agud Fernandez, et al.
Scientific Reports|July 13, 2017
Identification of differentially methylated BRCA1 and CRISP2 DNA regions as blood surrogate markers for cardiovascular diseaseGeoffrey Istas, Ken Declerck, Maria Pudenz, et al.
Food & Function|October 27, 2025
The impact of (poly)phenol-rich foods and extracts on flow-mediated dilation (FMD): a narrative reviewBrian Óg Murphy, Holly R Neill, Niamh Magee, et al.
Environmental Research|September 21, 2019
Association of residential air pollution, noise, and greenspace with initial ischemic stroke severityRosa Maria Vivanco-Hidalgo, Carla Avellaneda-Gómez, Payam Dadvand, et al.
ACS Infectious Diseases|March 22, 2016
Identification of "Preferred" Human Kinase Inhibitors for Sleeping Sickness Lead Discovery. Are Some Kinases Better than Others for Inhibitor Repurposing?Emanuele Amata, Hualin Xi, Gonzalo Colmenarejo, et al.
AIDS (London, England)|May 11, 2018
A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicityJhon Rojas, Jose L Blanco, Sonsoles Sanchez-Palomino, et al.
Pageof 77